Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2025)
Historic Interest & Investment Income for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $6.0 million.
- Indivior Pharmaceuticals' Interest & Investment Income rose 2000.0% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $23.0 million for FY2024, which is 4651.16% down from last year.
- Latest data reveals that Indivior Pharmaceuticals reported Interest & Investment Income of $6.0 million as of Q3 2025, which was up 2000.0% from $6.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Interest & Investment Income ranged from a high of $12.0 million in Q3 2023 and a low of $2.0 million during Q2 2022
- Its 4-year average for Interest & Investment Income is $7.2 million, with a median of $6.0 million in 2022.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Interest & Investment Income surged by 45000.0% in 2023, and later plummeted by 5833.33% in 2024.
- Indivior Pharmaceuticals' Interest & Investment Income (Quarter) stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then crashed by 50.0% to $5.0 million in 2024, then grew by 20.0% to $6.0 million in 2025.
- Its Interest & Investment Income was $6.0 million in Q3 2025, compared to $6.0 million in Q2 2025 and $4.0 million in Q1 2025.